New Radical IVF Treatment Developed in Australia That Saves Time, Reduces Stinging and Saves Money by Helping Women Get Pregnant
- In vitro maturation (IVM) treatment requires only two days of hormone injections
- Its fast treatment process makes it 90% cheaper than traditional IVF
- Women under 36 with a good egg reserve and AHM levels are eligible
An Australian breakthrough in fertility treatment has dramatically reduced the number of hormone injections needed and made IVF more affordable for women trying to have a baby.
Traditional IVF requires women to endure 12 to 14 days of hormone injections – the new treatment requires just two days of injections.
Sydney’s Royal Hospital for Women is the fifth site in the world to offer the new In Vitro Maturation (IVM) treatment, developed by Professor Rob Gilchrist of the University of NSW and colleagues in Brussels.
Under the new treatment, in vitro maturation (IVM), women will only need two days of hormone injections instead of the 12-14 days required with conventional IVF treatment ( stock picture)
The hospital’s head of obstetrics, Professor Bill Ledger, said the new development produces the same pregnancy rate and is less “burdensome” than conventional IVF.
“We only give the woman two or at most three injections of a low dose of the hormone…then we collect the immature eggs,” Ledger said.
“When they are fertilized they produce better quality embryos and we can achieve the same pregnancy rate with IVM as with IVF.”
Professor Ledger said the smaller eggs taken from a woman are slowly matured in a laboratory rather than in a woman’s womb, reducing the number of injections needed.
Director of Obstetrics at the Royal Hospital for Women in Sydney, Professor Bill Ledger (pictured), said the new treatment has the same pregnancy rate and is less ‘burdensome’ than IVF
“Using the treatment, doctors are able to collect much smaller 4-5 millimeter eggs from women and they are slowly matured in a lab in a special CAPA liquid that slows the process down to 24 to 48 hours,” Mr. Ledger told the Advertiser.
“In conventional IVF, the eggs have to mature inside a woman until they are about 18 or 20 millimeters in size, hence the need for more injections.
‘The patient could theoretically come to see me on Monday, we can do the injection on Tuesday, Wednesday and do the egg retrieval on Thursday. It’s over in no time.
The treatment reduced costs by 90%, from $4,000 to $400, as its faster turnaround time reduces drug use and hospital resources.
Starting this week, the hospital will offer the treatment to up to 60 women this year, with a third of all fertility patients receiving it in the future.
Women under 36 who have a good supply of eggs and good levels of the hormone AMH – a substance produced by cells in the ovarian follicles used to measure the quantity of eggs – will be eligible for treatment.
Women trying for a baby will experience fewer hormonal side effects such as bloating, nausea, and headaches, leading to fewer interruptions to their daily routines and work.
The faster process is a major development for women who need to freeze their eggs before undergoing severe cancer treatment.
“If their cancer is growing rapidly, they often don’t have time to complete conventional fertility treatment before starting chemotherapy, but it’s much more doable when only two hormone injections are needed,” said the Professor Leger.
The launch of IVM treatment at the Royal Hospital for Women coincides with fundraising for the hospital’s ‘Heart for Her’ foundation, which aims to raise funds for research and equipment.
Women under 36 with a good egg reserve and good AHM hormone levels are eligible for treatment due to start this week at the Royal Hospital for Women in Sydney (stock image)